Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.
- DOI
- 10.1007/s12185-026-04163-9
- Published
- 2026 Jun
- Container
- International journal of hematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12185-026-04163-9,
title = {Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.},
author = {Inano T and Sugimoto Y and Ohishi K and Gotoh A and Ito T and Ichii M and Shimoda K and Lin S and Zagrijtschuk O and Qin A and Sato M and Kawase H and Sato T and Komatsu N and Kirito K},
year = {2026},
journal = {International journal of hematology},
doi = {10.1007/s12185-026-04163-9},
url = {https://doi.org/10.1007/s12185-026-04163-9}
}RIS
TY - JOUR TI - Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study. AU - Inano T AU - Sugimoto Y AU - Ohishi K AU - Gotoh A AU - Ito T AU - Ichii M AU - Shimoda K AU - Lin S AU - Zagrijtschuk O AU - Qin A AU - Sato M AU - Kawase H AU - Sato T AU - Komatsu N AU - Kirito K PY - 2026 JO - International journal of hematology DO - 10.1007/s12185-026-04163-9 UR - https://doi.org/10.1007/s12185-026-04163-9 ER -
APA
T, I., Y, S., K, O., A, G., T, I., M, I., K, S., S, L., O, Z., A, Q., M, S., H, K., T, S., N, K., & K, K. (2026). Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.. International journal of hematology. https://doi.org/10.1007/s12185-026-04163-9
Source records
- pubmed · retrieved 2026-09-26T12:07:22.556Z